Double-Masked, Vehicle-Controlled, Randomized, Phase II Study of the Ocular Hypotensive Activity and Safety of VVN539 Ophthalmic Solution

Authors: David Wirta, MD, Xiao-Yan Li, MD, Wang Shen, PhD, Caroline Lu, MS, Gary D. Novack, PhD, William Christie, MD, Paul J. Hartman, MD, Lawrence Tafoya, MD, PhD, Navin Tekwani, MD

Source: Ophthalmology Science, Vol 4, Iss 2, Pp 100426- (2024)

Subject Terms: Glaucoma, Intraocular pressure, Ocular hypertension, Rho-kinase inhibitor, VVN539, Ophthalmology, RE1-994

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666914523001586; https://doaj.org/toc/2666-9145

Access URL: https://doaj.org/article/dd843ed5dee24a18aff6fd4d9405beb5